Additionally, we found that FOSL1 promotes stemness in GBM cells, thereby enhancing the survival of a subpopulation of stem‐like tumor cells known to exhibit greater resistance to standard therapies, including TMZ [31]. This evidence concerns the gene FOSL1 and neoplasm.